Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
13226 studies found for:    "Carcinoma"
Show Display Options
Rank Status Study
1 Recruiting MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Intervention: Drug: MLN0128
2 Active, not recruiting Epidemiologic Study of Hepatocellular Carcinoma in the US
Condition: Hepatocellular Carcinoma
Intervention:
3 Terminated Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: sorafenib (Nexavar®), thalidomide (Thado®)
4 Recruiting Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Laparoscopic liver resection;   Procedure: Open liver resection
5 Unknown  F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Interventions: Drug: Arm A: F16IL2 in combination with paclitaxel;   Drug: Arm B: Paclitaxel
6 Withdrawn Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
Condition: Urothelial Carcinoma
Interventions: Drug: Docetaxel;   Drug: ASA404
7 Unknown  Bevacizumab in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: bevacizumab
8 Completed
Has Results
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Axitinib (AG-013736);   Other: Best Supportive Care;   Drug: Placebo
9 Completed Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Dovitinib
10 Completed
Has Results
Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: OPB-31121;   Drug: OPB-31121 phase2
11 Completed Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
Condition: Squamous Cell Carcinoma
Intervention:
12 Completed Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib;   Drug: tegafur/uracil (UFUR®)
13 Unknown  Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: tumor maker interval shortly
14 Not yet recruiting Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma
Condition: Hepatic Carcinoma
Intervention:
15 Completed
Has Results
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Bevacizumab;   Drug: Erlotinib
16 Completed Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
Condition: Hepatocellular Carcinoma
Intervention: Procedure: chemoembolization ,Radiofrequency ablation
17 Active, not recruiting Stereotaxic Irradiation of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Radiation: Fiducials;   Radiation: CyberKnife
18 Terminated A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Adefovir Dipivoxil and Lamivudine
19 Active, not recruiting A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Intervention: Biological: GLA-SE
20 Withdrawn Treatment of Advanced Renal Cell Carcinoma With Quinacrine
Condition: Renal Cell Carcinoma
Intervention: Drug: quinacrine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.